Aegerion Pharmaceuticals, Inc.
(NASDAQ : AEGR)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Yes, 3x ETFs are Awesome!
Like TNA, UGAZ, UWTI, NUGT? We do too...Join Up!
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
PFEPfizer Inc.
0.05%41.940.9%$954.26m
JNJJohnson & Johnson
0.04%138.890.7%$780.65m
MRKMerck & Co., Inc.
0.22%81.200.6%$745.47m
BMYBristol-Myers Squibb Company
-0.99%46.831.4%$627.82m
LLYEli Lilly and Company
0.04%116.861.0%$478.55m
ABBVAbbVie, Inc.
-1.32%80.082.2%$408.18m
AZNAstraZeneca PLC Sponsored ADR
0.96%39.031.3%$191.83m
NVSNovartis AG Sponsored ADR
3.62%87.500.2%$171.58m
GSKGlaxoSmithKline plc Sponsored ADR
0.48%40.180.2%$97.11m
NVONovo Nordisk A/S Sponsored ADR Class B
0.43%48.590.1%$65.75m
SNYSanofi Sponsored ADR
0.40%42.280.2%$49.55m
LCILannett Company, Inc.
-7.14%5.6636.7%$9.52m
AKTXAkari Therapeutics Plc Sponsored ADR
-2.14%2.291.6%$0.41m
EPIXESSA Pharma Inc
21.95%2.500.1%$0.02m

Company Profile

Aegerion Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in the development and commercialization of therapies for patients with debilitating rare diseases. The company was founded by David I. Scheer and William H. Lewis in 2005 and is headquartered in Cambridge, MA.